Evidence map›Paper›PMID 33521456›Full record

ArticleACS omega2021

Nanocomposite of CuInS/ZnS and Nitrogen-Doped Graphene Quantum Dots for Cholesterol Sensing.

Rania Adel, Shaker Ebrahim, Azza Shokry, Moataz Soliman, Marwa Khalil

Abstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. A chitosan/rGO/FeRSC advances · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. PbFrontiers in chemistry · 2022
    Article
  10. Detection of HgACS omega · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rania AdelMaterials Science Department, Institute of Graduate Studies and Research, Alexandria University, P.O. Box, 163 Horreya Avenue, 21526 Alexandria, Egypt.
Shaker EbrahimMaterials Science Department, Institute of Graduate Studies and Research, Alexandria University, P.O. Box, 163 Horreya Avenue, 21526 Alexandria, Egypt.
Azza ShokryDepartment of Environmental Studies, Institute of Graduate Studies and Research, Alexandria University, P.O. Box, 163 Horreya Avenue, 21526 Alexandria, Egypt.
Moataz SolimanMaterials Science Department, Institute of Graduate Studies and Research, Alexandria University, P.O. Box, 163 Horreya Avenue, 21526 Alexandria, Egypt.
Marwa KhalilNanotechnology and Composite Materials Department, Institute of New Materials and Advanced Technology, City of Scientific Research and Technological Applications (SRTA-City), New Borg El Arab City, P.O. Box, 21934 Alexandria, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, nitrogen graphene quantum dots (N-GQDs) and copper indium sulfide/zinc sulfide (CIS/ZnS) QDs were synthesized via facile hydrothermal and aqueous solution routes, respectively. Herein, a fluorescent nanocomposite has been synthesized between N-GQDs and CIS/ZnS QDs in an aqueous phase. This nanocomposite was characterized by photoluminescence, Raman, and ultraviolet-visible (UV-vis) spectroscopies, high-resolution transmission electron microscopy (HRTEM), and X-ray diffraction (XRD). This fluorescent nanocomposite was developed as a highly sensitive, selective nonenzymatic cholesterol optical biosensor in 0.312-5 mM cholesterol. HRTEM micrographs confirmed the preparation of CIS/ZnS QDs and N-GQDs with average diameters of 3 and 5 nm, respectively. The as-prepared NG/CIS/ZnS QD nanocomposite had a high sensitivity for cholesterol with a wide linear range of concentration of 0.312-5 mM with an excellent correlation coefficient (

Identifiers

PMID33521456
PMCPMC7841935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.